PMC:7565665 / 1857-2127 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":81,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":81,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T29","span":{"begin":1,"end":3},"obj":"Disease"},{"id":"T30","span":{"begin":5,"end":8},"obj":"Disease"},{"id":"T31","span":{"begin":9,"end":13},"obj":"Disease"},{"id":"T32","span":{"begin":18,"end":26},"obj":"Disease"},{"id":"T33","span":{"begin":81,"end":94},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0009061"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T16","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T17","span":{"begin":81,"end":85},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-PubTator","denotations":[{"id":"46","span":{"begin":9,"end":13},"obj":"Disease"},{"id":"47","span":{"begin":18,"end":26},"obj":"Disease"},{"id":"61","span":{"begin":185,"end":196},"obj":"Species"},{"id":"63","span":{"begin":81,"end":94},"obj":"Disease"},{"id":"64","span":{"begin":127,"end":136},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:D012128"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:C000657245"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:12814"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D008171"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T13","span":{"begin":5,"end":8},"obj":"Phenotype"},{"id":"T14","span":{"begin":69,"end":94},"obj":"Phenotype"}],"attributes":[{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://www.orpha.net/ORDO/Orphanet_178320"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002091"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":29,"end":31},"obj":"Sentence"},{"id":"T11","span":{"begin":32,"end":44},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" CF, ALI/ARDS and COVID-19.\n\n1. Introduction\nChronic obstructive and restrictive lung diseases are among the leading causes of mortality worldwide, where acute or recurrent episodes of respiratory exacerbations are not only responsible for significant health care costs "}